User: Guest  Login
Document type:
journal article 
Author(s):
Perneczky, R; Kurz, A 
Title:
[Current antidementive therapy] 
Abstract:
Current antidementive treatment can delay further progress of the symptoms of dementia and should therefore be initiated as early as possible and be of adequate duration. Wherever possible, maximum permissible doses should be given. The efficacy of current antidementive drugs in Alzheimer's disease has been sufficiently documented by relevant studies. The acetylcholinesterase inhibitors, donepezil, galantamine and rivastigmine have been approved for the treatment of mild-to-moderate Alzheimer's...    »
 
Journal title abbreviation:
MMW Fortschr Med 
Year:
2004 
Journal volume:
146 Spec N 
Pages contribution:
53-6 
Language:
de 
Print-ISSN:
1438-3276 
TUM Institution:
r Psychiatrie und Psychotherapie